ResearchProjects

Women co-infected with HIV and HCV are at elevated risk for adverse health outcomes associated with alcohol use. This study adapted, implemented and tested an innovative computer-based alcohol reduction intervention among HIV/HCV co-infected women in clinical care to assess intervention efficacy in reducing alcohol use and HIV and HCV biological markers of disease progression.

Abstract on NIH RePORTER

Brown JL, Capasso A, Revzina N, Boeva E, Rassokhin V, Sales JM, Gutova LV, Khalezova NB, Hitch AE, Twitty TD, DiClemente RJ (2023).
Concordance of ethyl glucuronide, blood alcohol content, and self-reported alcohol use in Russian women with HIV and hepatitis C virus co-infection
AIDS and Behavior, 27 (12), 4062-4069. doi: 10.1007/s10461-023-04120-1.

Brown JL, Anastasakis I, Revzina N, Capasso A, Boeva E, Rassokhin V, Crusey A, Sales JM, Hitch A, Renfro T, DiClemente RJ (2021).
Development and cultural adaptation of a computer-delivered and multi-component alcohol reduction intervention for Russian women living with HIV and HCV
Journal of the International Association of Providers of AIDS Care, 20, 23259582211044920. doi: 10.1177/23259582211044920. PMCID: PMC8532257.

Capasso A, Brown JL, Safonova P, Belyakov N, Rassokhin V, DiClemente RJ (2021).
Heavy alcohol use is associated with lower CD4 counts among Russian women living with HIV: A multilevel analysis
AIDS and Behavior, 25 (11), 3734-3742. doi: 10.1007/s10461-021-03270-4. PMCID: PMC9116280.

DiClemente RJ, Brown JL, Capasso A, Revzina N, Sales JM, Boeva E, Gutova LV, Khalezova NB, Belyakov N, Rassokhin V (2021).
Computer-based alcohol reduction intervention for alcohol-using HIV/HCV co-infected Russian women in clinical care: Study protocol for a randomized controlled trial
Trials, 221 (1), 147. doi: 10.1186/s13063-021-05079-x. PMCID: PMC7887790.